Use of an absorbent dressing specifically for fecal incontinence

Managing Faecal INcontinence in people with advanced dementia resident in Care Homes (FINCH) study: a realist synthesis of the evidence

BACKGROUND

Eighty per cent of care home residents in the UK are living with dementia. The prevalence of faecal incontinence (FI) in care homes is estimated to range from 30% to 50%. There is limited evidence of what is effective in the reduction and management of FI in care homes.

OBJECTIVE

To provide a theory-driven explanation of the effectiveness of programmes that aim to improve FI in people with advanced dementia in care homes.

DESIGN

A realist synthesis. This was an iterative approach that involved scoping of the literature and consultation with five stakeholder groups, a systematic search and analysis of published and unpublished evidence, and a validation of programme theories with relevant stakeholders.

DATA SOURCES

The databases searched included PubMed, Cumulative Index to Nursing and Allied Health Literature, The Cochrane Library, Scopus, SocAbs, Applied Social Sciences Index and Abstracts, BiblioMap, Sirius, OpenGrey, Social Care Online and the National Research Register.

RESULTS

The scoping identified six programme theories with related context-mechanism-outcome configurations for testing. These addressed (1) clinician-led support, assessment and review, (2) the contribution of teaching and support for care home staff on how to reduce and manage FI, (3) the causes and prevention of constipation, (4) how the cognitive and physical capacity of the resident affect outcomes, (5) how the potential for recovery, reduction and management of FI is understood by those involved and (6) how the care of people living with dementia and FI is integral to the work patterns of the care home and its staff. Data extraction was completed on 62 core papers with iterative searches of linked literature. Dementia was a known risk factor for FI, but its affect on the uptake of different interventions and the dementia-specific continence and toileting skills staff required was not addressed. Most care home residents with FI will be doubly incontinent and, therefore, there is limited value in focusing solely on FI or on single causes of FI such as constipation. Clinical assessment, knowledge of the causes of FI and strategies that recognise the individuals' preferences are necessary contextual factors. Valuing the intimate and personal care work that care home staff provide to people living with dementia and addressing the dementia-related challenges when providing continence care within the daily work routines are key to helping to reduce and manage FI in this population.

LIMITATIONS

The synthesis was constrained by limited evidence specific to FI and people with dementia in care homes and by the lack of dementia-specific evidence on continence aids.

CONCLUSIONS

This realist synthesis provides a theory-driven understanding of the conditions under which improvement in care for care home residents living with dementia and FI is likely to be successful.

FUTURE WORK

Future multicomponent interventions need to take account of how the presence of dementia affects the behaviours and choices of those delivering and receiving continence care within a care home environment.

STUDY REGISTRATION

This study is registered as PROSPERO CRD42014009902.

FUNDING

The National Institute for Health Research Health Technology Assessment programme.

Use and evaluation of disposable absorbent products for managing fecal incontinence by community-living people

PURPOSE

The use of disposable absorbent products by community-dwelling people with fecal incontinence (FI) was described.

METHODS

A survey was administered to 189 community-living individuals with FI at the start of a clinical trial about the effects of dietary fiber on FI.

RESULTS

Forty-five percent of respondents (86/189) used an absorbent product to manage FI. More women (88%, 76/86, P = .009) and persons aged 65 years and older (44%, 38/86, P = .001) wore an absorbent product. Participants who wore an absorbent product for FI had a higher (worse) FI severity score (median, 4.75; range, 1-27; P = .006). Sixty-three users wore pantiliners and they were the only ones who used more than 3 products per day. Feminine hygiene products were worn more than incontinence products. Half of users were satisfied with the product they used. Evaluations of product features differed by type of product; odor control had some of the lowest ratings.

CONCLUSIONS

Community-living individuals with FI, especially women and older individuals, tend to wear absorbent products. Perceptions of FI severity, preference, leakage of liquid stool, and presence of urinary incontinence influence the product type and pattern of wear. Participants report that modification of several features of absorbent products might make them more suitable for FI and increase satisfaction.

Approach to fecal incontinence and constipation in older hospitalized patients

Although constipation and fecal incontinence are commonly encountered in older hospitalized patients, there is a paucity of clinical studies in this field. In this article we discuss the approach to and management of patients with these problems based on evidence and studies performed on patients in the ambulatory care setting, nursing home setting, and our experience. Our recommendations are applicable to older hospitalized patients. Successful management of these patients depends on identifying and treating underlying cause(s), such as infection, dietary factors, medication, or immobility-induced incontinence, constipation, or fecal impaction. For a hospitalized patient, a digital rectal examination should be performed to rule out fecal impaction and overflow incontinence. If there is no impaction but a weak anal sphincter, stool softeners or laxatives should be discontinued, as they cause diarrhea/fecal incontinence. In a patient with diarrhea/incontinence and suspected infection, management includes checking stool for Clostridium difficile toxin, E0157, ova and parasites, and culture. If the patient is on enteral nutrition, osmotic diarrhea-induced incontinence should be considered. Nursing care includes use of absorbent pads, special undergarments, anal hygiene, and skin care. Medications such as loperamide or diphenoxylate/atropine are useful for diarrhea with incontinence. Laxatives (eg, polyethylene glycol, lactulose), secretagogues (eg, lubiprostone), enemas, suppositories, and timed toileting assistance may be effective for constipation. Despite appropriate management, older hospitalized patients may remain incontinent because of dementia, immobility, or comorbid issues. Treatment should be tailored to the underlying mechanism(s) and needs of each patient.

Fecal incontinence in the elderly

Fecal incontinence affects up to 20% of community-dwelling adults and more than 50% of nursing home residents, and is one of the major risk factors for elderly persons in the nursing home. Institutionalization itself is a risk factor (eg, immobility due to physical restraints). Management should focus on identifying and treating underlying causes, such as diet- or medication induced diarrhea, constipation, and fecal impaction. Use of absorbent pads and special undergarments is useful. Anorectal physiologic testing of nursing home residents has revealed an association between constipation, stool retention, and fecal incontinence. Impaired sphincter function (risk factor for fecal incontinence), decreased rectal sensation, and sphincter dyssynergia (risk factor for constipation and impaction) are found in a high proportion of incontinent nursing home residents. Biofeedback and sacral nerve stimulation may be useful in refractory patients and should be considered before colostomy in community-dwelling adults. Despite appropriate management, nursing home residents may remain incontinent because of dementia and health or restraint related immobility.

Building the evidence base--the Zassi Bowel Management System

Uncontrolled faecal incontinence (FI) secondary to diarrhoea represents a major risk to perianal skin integrity and the healing of perineal wounds or burns. In an era of heightened awareness of the morbidity and the costs associated with hospital-acquired infection, there are obvious concerns about the risks of cross-infection associated with diarrhoea or FI. This article evaluates the Zassi Bowel Management System (ZBMS, Hollister), a product that has been designed to manage diarrhoea, faecal incontinence and defaecation in situations where a patient is either completely dependent, has overwhelming uncontrolled diarrhoea that poses a threat to skin integrity and is a cross-infection risk, or where normal defaecation poses a risk to wound integrity and sterility.

Riding the research roller coaster: what went right, what went wrong?

Evidence-based practice drives nursing procedures and standards of care. Supporting practice with valid research can be a challenge. After identifying a knowledge- and problem-focused trigger, a group of WOC nurses began a research journey. Our purpose was to determine the effectiveness of the rectal trumpet compared to the fecal collector in maintaining skin integrity in patients with fecal incontinence. The methodology included a convenience sample of 100 patients randomized to rectal trumpet or fecal collector versus standard care. Data were collected on signs of increased skin breakdown or healing, stool leakage around device, dislodgement, and discomfort from device. This article will reveal our journey in conducting this clinical research. After many challenges, the study was terminated, but the experiences and lessons learned during our efforts were invaluable. Even well-planned studies can encounter problems that prevent completion. It is important to evaluate these problems so that lessons can be learned and shared. This is our roller coaster ride in the research world.

Fecal incontinence and biofeedback therapy

Biofeedback as delivered in most clinical settings in Western medicine has been consistently reported to improve symptoms of fecal incontinence. Closer scrutiny of the elements of the intervention and controlled studies, however, have consistently failed to find any benefit of the biofeedback element of this complex package of care; nor has any superiority been found for one modality over another. There is a need for further well-designed and adequately powered randomized controlled trials. Meanwhile, there can be little doubt that conservative interventions improve many patients with fecal incontinence to the point where most report satisfaction with treatment and do not wish to consider more invasive options, such as surgery.